Citadel Advisors
COCH icon

Citadel Advisors’s Envoy Medical COCH Stock Holding History

Citadel Advisors’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88,440
Closed -$58.5K – 13132
2025
Q4 		$58.5K Buy
+88,440
New +$70K ﹤0.01% 11950
2025
Q1 		– Sell
-28,314
Closed -$41.6K – 14603
2024
Q4 		$41.6K Buy
+28,314
New +$64.3K ﹤0.01% 12578
2023
Q2 		– Sell
-175,115
Closed -$1.76M – 14442
2023
Q1 		$1.76M Sell
175,115
-324,885
-65% -$3.26M ﹤0.01% 5629
2022
Q4 		$5.05M Sell
500,000
-135
-0% -$1.34K ﹤0.01% 3841
2022
Q3 		$4.92M Buy
500,135
+17
+0% +$167 ﹤0.01% 3906
2022
Q2 		$4.9M Sell
500,118
-288
-0.1% -$2.82K ﹤0.01% 3825
2022
Q1 		$4.89M Buy
500,406
+399
+0.1% +$3.88K ﹤0.01% 4218
2021
Q4 		$4.88M Buy
500,007
+7
+0% +$68 ﹤0.01% 4333
2021
Q3 		$4.85M Buy
+500,000
New +$4.84M ﹤0.01% 4359

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Citadel Advisors's COCH Position: Q1 2026 in Review

Citadel Advisors sold out of Envoy Medical (COCH) in Q1 2026, closing a stake of 88,440 shares — an estimated $58.5K sold.

Citadel Advisors first reported a position in COCH in Q3 2021 and held it in 9 quarters. The position peaked at $5.05M in Q4 2022. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Citadel Advisors reported no remaining Envoy Medical position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 88,440 Envoy Medical shares in Q1 2026, an estimated $58.5K.
  • Citadel Advisors first reported a position in Envoy Medical in Q3 2021 and held it in 9 quarters.
  • Citadel Advisors's Envoy Medical position peaked at $5.05M in Q4 2022.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.